Related Experiment Video
Updated: May 2, 2026
08:01
Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
6.9K
Palmitoylethanolamide: problems regarding micronization, ultra-micronization and additives.
1JP Rusell Science Ltd, Nicosia, Cyprus, rutger.kriek@equationcs.com.
Inflammopharmacology
|March 21, 2014
Summary
This commentary questions the scientific rigor of a study on Palmitoylethanolamide (PEA) for neuropathic pain due to potential conflicts of interest and lack of proper comparative analysis for micronized PEA formulations.
Area of Science:
- Pharmacology
- Clinical Practice
- Pain Management
Background:
- A study in 'Inflammopharmacology' claims Palmitoylethanolamide (PEA) modifies neuropathic pain.
- Authors have ties to companies producing micronized and ultra-micronized PEA.
Purpose of the Study:
- To evaluate the scientific validity of claims regarding micronized PEA formulations.
- To assess adherence to Good Clinical Practice and scientific standards.
Main Methods:
- Critical review of the cited study and relevant literature.
- Analysis of potential conflicts of interest.
- Evaluation of comparative study design for PEA formulations.
Main Results:
- The original study lacks a direct comparison between pure PEA and its micronized forms.
- Potential bias due to author affiliations with PEA manufacturers.
- Concerns regarding the impact of additives in commercial PEA products.
Conclusions:
- The claim that micronized PEA is superior is unsubstantiated by the study's methodology.
- Pure PEA without additives is recommended over micronized formulations pending further rigorous research.
More Related Videos
Related Concept Videos
01:16Bioavailability Enhancement: Drug Solubility Enhancement
499
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
499
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
01:27Bioavailability Enhancement: Drug Permeability Enhancement
352
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
352
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.9K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.9K
01:30Micelles
364
Micelle formation is an intricate process that hinges on the properties of amphiphilic or amphipathic molecules and the conditions of the system in which they are found. Amphiphilic molecules, which have both hydrophilic (water-attracting) and hydrophobic (water-repelling) parts, play a critical role in this process.In aqueous environments, these molecules arrange themselves such that their hydrophilic heads are turned towards the water phase, while their hydrophobic tails are oriented away...
364
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332